BioPharma Dive July 3, 2023
Sponsored content By iliomad Health Data

U.S. life sciences companies that conduct trials in Europe must deal with more than language nuances and time-zone differences. They must also comply with the General Data Protection Regulation (GDPR). This bedrock privacy regulation controls the use of all personal data, not just health data, of persons residing in the EU and the UK. And thanks to its extraterritorial scope, it applies to U.S. trial sponsors, even if they don’t have offices in the EU and the UK.

In this article, we’ll discuss what the GDPR is and why it matters to your life sciences company. We’ll also show you how iliomad Health Data can help you maintain GDPR compliance.

A Brief Overview of the GDPR

The EU adopted the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Clinical Trials, Govt Agencies, Healthcare System, Pharma, Pharma / Biotech, Privacy / Security, Regulations, Trends
Non-binding Guidance: Clinical Trial Diversity in Focus
NIH algorithm matches patients to clinical trials
GLP-1 reduced heart failure risk by 46%: 8 study takeaways
Pregnant People Can Freely Make Decisions About Participation In Clinical Research
InnovationRx: Positive Clinical Trial Results For Generative AI-Designed Drug

Share This Article